Published Nov 1, 2016
Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel this afternoon entitled, Emerging US Value Frameworks: Are There Lessons From – Or For – Europe? The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.  The issue panel was moderated by Richard J. Willke, PhD, Chief Science Officer, ISPOR, Lawrenceville, NJ, USA. Speakers for the session included:
  • Peter J. Neumann, ScD, Professor and Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts University, Boston, MA, USA
  • Michael F. Drummond, MCom, DPhil, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK
  • Finn Børlum Kristensen, MD, PhD, Professor, University of Southern Denmark, Hilleroed, Denmark
ISPOR is spearheading the Initiative on US Value Assessment Frameworks to inform the shift towards a value-driven health care system in the US by promoting the development and dissemination of high-quality, unbiased value assessment frameworks. A Special Task Force has been convened as part of the Initiative that will collaborate to produce a white paper that advises on the appropriate definition and use of high-quality value frameworks. This issue panel discussed the methodological issues that have raised concerns about the validity of the current US value frameworks. The panel noted that existing European health technology assessment (HTA) guidelines, such as the EUnetHTA HTA Core Model®, already consider these methodological issues. The panel considered how the ISPOR Special Task Force adapt and potentially improve upon these European value framework approaches in the development of US value frameworks. Information of the ISPOR Initiative on US Value Assessment Frameworks can be found here. Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.


Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now